Biomedical applications of Polymers from Scaffolds to
Nanostructures
The ability of polymers to span wide ranges of mechanical
properties and morph into desired shapes makes them useful for a
variety of applications, including scaffolds, self-assembling
materials, and nanomedicines. With an interdisciplinary list of
subjects and contributors, this book overviews the biomedical
applications of polymers and focuses on the aspect of regenerative
medicine. Chapters also cover fundamentals, theories, and tools for
scientists to apply polymers in the following ways:
* Matrix protein interactions with synthetic surfaces
* Methods and materials for cell scaffolds
* Complex cell-materials microenvironments in bioreactors
* Polymer therapeutics as nano-sized medicines for tissue
repair
* Functionalized mesoporous materials for controlled
delivery
* Nucleic acid delivery nanocarriers
Concepts include macro and nano requirements for polymers as
well as future perspectives, trends, and challenges in the field.
From self-assembling peptides to self-curing systems, this book
presents the full therapeutic potential of novel polymeric systems
and topics that are in the leading edge of technology.
Об авторе
Manuel Monleón Pradas is Professor at the Technical
University of Valencia, Spain, where he founded and headed the
Centre for Biomaterials and Tissue Engineering (1999-2009).
He was Head of the Biomaterials Unit at the Centro de
Investigación Príncipe Felipe (Valencia, Spain), and has
been visiting professor at the University of Paris-XI. He has
authored over 160 papers in the fields of polymer science and
biomaterials.
María J. Vicent is Head of the Polymer Therapeutics
Laboratory at Centro de Investigación Príncipe Felipe
(Valencia, Spain). She has expertise in several aspects of polymer
therapeutics field, from synthesis of nanopharmaceutics to their
biological evaluation in different cell and in vivo models. Dr.
Vicent has coauthored over 70 papers and 7 patents in the field.
Furthermore, in 2012, she cofounded a spin-off company named
Polypeptide Therapeutic Solutions SL, Spain, based on a family
patent from her own group.